NovaBridge Biosciences (NBP) — Capital Reinvestment Ratio
NovaBridge Biosciences (NBP) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($13.15 Million) in capital expenditures ($41.00). Check NBP goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NovaBridge Biosciences Capital Reinvestment Ratio (2020–2020)
This chart tracks NovaBridge Biosciences's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does NovaBridge Biosciences generate cash.
Annual Capital Reinvestment Ratio for NovaBridge Biosciences (2020–2020)
Year-by-year Capital Reinvestment Ratio for NovaBridge Biosciences from 2020 to 2020. See NBP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | $433.56 Million | $8.01 Million | — |